Healthcare and Life Science Innovation

A platform for building a constructive dialog

Awareness through dialog

The Healthcare and Life Science Innovation committee is a platform for building a constructive dialog among all healthcare ecosystem stakeholders (patients, HCPs, industry and regulators).

Our Goal

Our goal is to make healthcare one of the top government priorities by identifying the exact need for more awareness around non-communicable diseases.

Creating

Awareness

Creating awareness around Non-communicable diseases (NCDs) because they are the leading cause of death and disability globally* (diabetes, cardiovascular disease, cancer, etc) as well as obesity. Raising awareness is a key step towards reducing the risk of developing NCDs-related complications that might develop overtime. Improved knowledge about such chronic conditions as for example diabetes or obesity will help to eradicate stigma and discrimination, two significant barriers to effective prevention and care. Risk reduction will also be achieved through the implementation of policies that support health-enabling environments, tackle social and health inequalities and promote early action. This is a key component of risk-reduction strategies, notably addressing the challenge posed by nearly half of Lithuanians living with diabetes, who have not been diagnosed, and are, therefore, at increased risk of diabetes-related complications.

Integrated

Care

Integrated care has been identified as one of the main priorities for people living with chronic conditions such as diabetes, obesity or CVD and those at risk. To ensure a coordinated approach across multiple providers, primary care systems need to be strengthened; there needs to be closer interaction and coordination between and among the different levels of care and most importantly, the patient has to be placed at the centre of their care.

Improving

Access

Improving access to innovative healthcare solutions and therapies. People with NCDs can live life to the full. This requires, however, the ability to access the medicines, supplies, technologies and care they require on an uninterrupted basis.

* Roth GA, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1736–1788.